These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8545123)

  • 1. Induction of apoptosis by rho in NIH 3T3 cells requires two complementary signals. Ceramides function as a progression factor for apoptosis.
    Esteve P; del Peso L; Lacal JC
    Oncogene; 1995 Dec; 11(12):2657-65. PubMed ID: 8545123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of apoptosis in NIH3T3 cells after serum deprivation by overexpression of rho-p21, a GTPase protein of the ras superfamily.
    Jiménez B; Arends M; Esteve P; Perona R; Sánchez R; Ramón y Cajal S; Wyllie A; Lacal JC
    Oncogene; 1995 Mar; 10(5):811-6. PubMed ID: 7898922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumorigenic activity of rho genes from Aplysia californica.
    Perona R; Esteve P; Jiménez B; Ballestero RP; Ramón y Cajal S; Lacal JC
    Oncogene; 1993 May; 8(5):1285-92. PubMed ID: 8479750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GTP-binding protein-stimulated phospholipase C and phospholipase D activities in ras-transformed NIH 3T3 fibroblasts.
    Quilliam LA; Der CJ; Brown JH
    Second Messengers Phosphoproteins; 1990; 13(1):59-67. PubMed ID: 2149569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of type D phospholipase by serum stimulation and ras-induced transformation in NIH3T3 cells.
    Carnero A; Cuadrado A; del Peso L; Lacal JC
    Oncogene; 1994 May; 9(5):1387-95. PubMed ID: 8152799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway.
    Esteve P; Embade N; Perona R; Jiménez B; del Peso L; León J; Arends M; Miki T; Lacal JC
    Oncogene; 1998 Oct; 17(14):1855-69. PubMed ID: 9778052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies.
    Podo F; Ferretti A; Knijn A; Zhang P; Ramoni C; Barletta B; Pini C; Baccarini S; Pulciani S
    Anticancer Res; 1996; 16(3B):1399-412. PubMed ID: 8694508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells.
    Frankel P; Ramos M; Flom J; Bychenok S; Joseph T; Kerkhoff E; Rapp UR; Feig LA; Foster DA
    Biochem Biophys Res Commun; 1999 Feb; 255(2):502-7. PubMed ID: 10049738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML; Chou YW; Chau YP; Huang TS
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell and tissue-type specific expression of Ras-related GTPase RhoB.
    Fritz G; Gnad R; Kaina B
    Anticancer Res; 1999; 19(3A):1681-8. PubMed ID: 10470101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeranylated, but not farnesylated, RhoB suppresses Ras transformation of NIH-3T3 cells.
    Mazières J; Tillement V; Allal C; Clanet C; Bobin L; Chen Z; Sebti SM; Favre G; Pradines A
    Exp Cell Res; 2005 Apr; 304(2):354-64. PubMed ID: 15748883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells.
    Chou CK; Liang KH; Tzeng CC; Huang GC; Chuang JI; Chang TY; Liu HS
    Life Sci; 2006 Mar; 78(16):1823-9. PubMed ID: 16274703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased retinoylation in NIH 3T3 cells transformed with activated Ha-ras.
    Takahashi N; De Luca LM; Breitman TR
    Biochem Biophys Res Commun; 1997 Oct; 239(1):80-4. PubMed ID: 9345273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic phospholipase D activity is restricted to caveolin-enriched membrane microdomains.
    Xu L; Shen Y; Joseph T; Bryant A; Luo JQ; Frankel P; Rotunda T; Foster DA
    Biochem Biophys Res Commun; 2000 Jun; 273(1):77-83. PubMed ID: 10873567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low molecular weight factor from dividing cells activates phospholipase D in caveolin-enriched membrane microdomains.
    Bychenok S; Foster DA
    Arch Biochem Biophys; 2000 May; 377(1):139-45. PubMed ID: 10775453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton.
    Koch G; Benz C; Schmidt G; Olenik C; Aktories K
    J Pharmacol Exp Ther; 1997 Nov; 283(2):901-9. PubMed ID: 9353412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
    Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
    Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho small G protein and cytoskeletal control.
    Takai Y; Kaibuchi K; Sasaki T; Tanaka K; Shirataki H; Nakanishi H
    Princess Takamatsu Symp; 1994; 24():338-50. PubMed ID: 8983086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
    Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
    Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.